Current research is focused on understanding the detailed mechanisms of RPLP0 in ribosome function and its role in disease. Studies are exploring its potential as a diagnostic biomarker and therapeutic target in cancer. Additionally, research is being conducted to elucidate its interactions with other ribosomal proteins and translation factors.
